3Fleminga FJ, Hill AD, McDermott EW, et al. Intraoperative margin assessment and re-excision rate in breast conserving surgery [J]. Eur J Surg Oncol,2004,30(3 ) :233 -237.
4Scopa CD,Aroukatos P, Athanassios C, et al. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma[J]. Breast J,2006,12(2) :150 - 153.
5Leong C, Boyages J, Jayasinghe UW, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma[ J]. Cancer,2004, 100(9) :1823 - 1832.
6Dillon MF, Hill AD, Quinn CM, et al. Pathologic assessment of adequate margin status in breast-conserving therapy [ J ]. Ann Surg Oncol,2006,13 ( 3 ) : 333 - 339.
7Neuschatz AC, Dipetrilo T, Safaii H, et al. Long-term follow-up pf a pmspective policy of margin-directed radiation dose escalation in breast-conserving therapy [ J ]. Cancer,2003,97 (1) :30- 39.
8Perez CA. Conservation Therapy in T1 - T2 breast cancer: past, current issues, and future challenges and opportunities [J]. Cancer J,2003,9(6) :442 -453.
9Early breast cancer trialists collaborative group (EBCTCG). Efficts of radiotherapy and surgery in early breast cancer: an overview of the randomised trials [ J ]. N Engl J Med, 1995,333 ( 22 ) : 1444 - 1455.
10Cabioglu N, Hunt KK, Buchholz TA, et al. Improving local control with breast-conserving therapy a 27-year single-institution experience [ J ].Cancer,2005,104 ( 1 ) :20 - 29.
